These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37365983)

  • 1. Hormone replacement therapy did not increase risk of melanoma in Chinese female with menopausal and postmenopausal disorders: A population-based retrospective cohort study in Taiwan.
    Ma J; Chen YH; Chiang CP; Wang WM; Chung CH; Tsao CH; Weng ZX; Hung CT; Chien WC
    J Dermatol; 2023 Sep; 50(9):1162-1169. PubMed ID: 37365983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
    Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
    Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database.
    Inayama Y; Mizuno K; Yamaguchi K; Hamanishi J; Takeuchi M; Egawa M; Mandai M; Kawakami K
    J Obstet Gynaecol Res; 2023 Jul; 49(7):1805-1814. PubMed ID: 37029559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
    Tang JY; Spaunhurst KM; Chlebowski RT; Wactawski-Wende J; Keiser E; Thomas F; Anderson ML; Zeitouni NC; Larson JC; Stefanick ML
    J Natl Cancer Inst; 2011 Oct; 103(19):1469-75. PubMed ID: 21878677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
    Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E
    Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and the risk of breast cancer.
    Narod SA
    Nat Rev Clin Oncol; 2011 Aug; 8(11):669-76. PubMed ID: 21808267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
    Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and menopause: a review of randomized, double-blind, placebo-controlled trials.
    Chang C; Lin CH
    Kaohsiung J Med Sci; 2003 Jun; 19(6):257-70. PubMed ID: 12873034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone Replacement Therapy and Psoriasis Risk: A Nationwide Population-Based Cohort Study.
    Go GM; Oh HJ; Han K; Kim YH; Lee HJ; Lee JH
    J Korean Med Sci; 2023 Dec; 38(49):e377. PubMed ID: 38111280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and dry eye syndrome.
    Schaumberg DA; Buring JE; Sullivan DA; Dana MR
    JAMA; 2001 Nov; 286(17):2114-9. PubMed ID: 11694152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women.
    Dinger J; Bardenheuer K; Heinemann K
    Climacteric; 2016 Aug; 19(4):349-56. PubMed ID: 27174159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women.
    de Lignières B; de Vathaire F; Fournier S; Urbinelli R; Allaert F; Le MG; Kuttenn F
    Climacteric; 2002 Dec; 5(4):332-40. PubMed ID: 12626212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopausal hormone therapy and melanoma risk in the Australian longitudinal study on women's health.
    Botteri E; Xu Z; Støer NC; Mishra GD
    Maturitas; 2022 Jun; 160():1-3. PubMed ID: 35550702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and endometrial cancer.
    Emons G; Huschmand-Nia A; Krauss T; Hinney B
    Onkologie; 2004 Apr; 27(2):207-10. PubMed ID: 15138357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
    Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
    Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.